Welcome Jeymi Tambiah!
Genascence is pleased to welcome Jeymi Tambiah as our new chief medical officer. An accomplished physician-scientist, Jeymi brings more than 15 years’ biopharmaceutical industry experience creating and leading strategies for medical affairs, clinical development, and drug development programs, as well as a deep bench strength in translational medicine, commercialization, and health outcomes research to Genascence. “Jeymi is a visionary leader skilled at leveraging scientific and clinical expertise to build innovative first-in-class therapeutic programs in the areas of #osteoarthritis, immunology, oncology, and neuroscience,” said Thomas W. Chalberg, PhD, founder and CEO of Genascence. “His development and research expertise, particularly within the osteoarthritis research community, will be invaluable as we execute on our strategy to bring #genetherapy to people suffering from prevalent #musculoskeletaldiseases.” Read more in our press release https://bit.ly/4eYLhQ8